1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Invitro Diagnostics Market, By Product and Service
5.1 Introduction
5.2 Reagents & Kits
5.3 Instruments
5.4 Services
5.5 Data Management Software
6 Global Invitro Diagnostics Market, By Technology
6.1 Introduction
6.2 Immunoassay/ Immunochemistry
6.3 Hematology
6.4 Microbiology
6.5 Urinalysis
6.6 Clinical Chemistry
6.7 Molecular Diagnostics
6.8 Coagulation and Hemostasis
6.9 Other Technologies
7 Global Invitro Diagnostics Market, By Application
7.1 Introduction
7.2 Infectious Diseases
7.3 Drug Testing/ Pharmacogenomics
7.4 Oncology
7.5 HIV/AIDS
7.6 Diabetes
7.7 Autoimmune Diseases
7.8 Cardiology
7.9 Nephrology
7.10 Other Applications
8 Global Invitro Diagnostics Market, By End User
8.1 Introduction
8.2 Hospital Laboratories
8.3 Academic Institutes
8.4 Patients
8.5 Point-of-Care Testing Centers
8.6 Clinical Laboratories
8.7 Other End Users
9 Global Invitro Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Freenome Holdings, Inc.
11.2 Agilent Technologies, Inc.
11.3 Natera, Inc.
11.4 Exact Sciences Corporation
11.5 F. Hoffmann-La Roche Ltd.
11.6 Abbott Laboratories
11.7 Sysmex Corporation
11.8 Siemens Healthineers AG
11.9 BD (Becton, Dickinson, and Company)
11.10 Quest Diagnostics Incorporated
11.11 Bio-Rad Laboratories, Inc.
11.12 Alere, Inc.
11.13 InterVenn Biosciences
11.14 Guardant Health
11.15 Thermo Fisher Scientific, Inc.
11.16 NeoGenomics Laboratories
11.17 Invitae Corporation
11.18 Beckman Coulter
11.19 Danaher
11.20 Illumina, Inc.
List of Tables
Table 1 Global Invitro Diagnostics Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Invitro Diagnostics Market Outlook, By Product and Service (2021-2030) ($MN)
Table 3 Global Invitro Diagnostics Market Outlook, By Reagents & Kits (2021-2030) ($MN)
Table 4 Global Invitro Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
Table 5 Global Invitro Diagnostics Market Outlook, By Services (2021-2030) ($MN)
Table 6 Global Invitro Diagnostics Market Outlook, By Data Management Software (2021-2030) ($MN)
Table 7 Global Invitro Diagnostics Market Outlook, By Technology (2021-2030) ($MN)
Table 8 Global Invitro Diagnostics Market Outlook, By Immunoassay/ Immunochemistry (2021-2030) ($MN)
Table 9 Global Invitro Diagnostics Market Outlook, By Hematology (2021-2030) ($MN)
Table 10 Global Invitro Diagnostics Market Outlook, By Microbiology (2021-2030) ($MN)
Table 11 Global Invitro Diagnostics Market Outlook, By Urinalysis (2021-2030) ($MN)
Table 12 Global Invitro Diagnostics Market Outlook, By Clinical Chemistry (2021-2030) ($MN)
Table 13 Global Invitro Diagnostics Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
Table 14 Global Invitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2021-2030) ($MN)
Table 15 Global Invitro Diagnostics Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 16 Global Invitro Diagnostics Market Outlook, By Application (2021-2030) ($MN)
Table 17 Global Invitro Diagnostics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
Table 18 Global Invitro Diagnostics Market Outlook, By Drug Testing/ Pharmacogenomics (2021-2030) ($MN)
Table 19 Global Invitro Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
Table 20 Global Invitro Diagnostics Market Outlook, By HIV/AIDS (2021-2030) ($MN)
Table 21 Global Invitro Diagnostics Market Outlook, By Diabetes (2021-2030) ($MN)
Table 22 Global Invitro Diagnostics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
Table 23 Global Invitro Diagnostics Market Outlook, By Cardiology (2021-2030) ($MN)
Table 24 Global Invitro Diagnostics Market Outlook, By Nephrology (2021-2030) ($MN)
Table 25 Global Invitro Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
Table 26 Global Invitro Diagnostics Market Outlook, By End User (2021-2030) ($MN)
Table 27 Global Invitro Diagnostics Market Outlook, By Hospital Laboratories (2021-2030) ($MN)
Table 28 Global Invitro Diagnostics Market Outlook, By Academic Institutes (2021-2030) ($MN)
Table 29 Global Invitro Diagnostics Market Outlook, By Patients (2021-2030) ($MN)
Table 30 Global Invitro Diagnostics Market Outlook, By Point-of-Care Testing Centers (2021-2030) ($MN)
Table 31 Global Invitro Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
Table 32 Global Invitro Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
